We are live on ! Find out more
PVMCV

Polaris Venture Management Co V Portfolio holdings

AUM $14.1M
1-Year Est. Return 121.41%
This Fund
S&P 500
This Quarter Est. Return
+42.48%
1 Year Est. Return
+121.41%
3 Year Est. Return
+281.18%
5 Year Est. Return
+1,023.01%
10 Year Est. Return
–
AUM
$118M
AUM Growth
+$24.5M
Cap. Flow
-$4.42M
Cap. Flow %
-3.74%
Top 10 Hldgs %
99.23%
Holding
12
New
–
Increased
1
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
RNAC icon
Cartesian Therapeutics
RNAC
+$2.46M

Top Sells

Rank Stock Value
1
FATE icon
Fate Therapeutics
FATE
+$5.52M
2
STIM icon
Neuronetics
STIM
+$1.36M

Sector Composition

Rank Sector Weight
1 Healthcare 59.95%
2 Communication Services 35.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CDLX icon
1
Cardlytics
CDLX
$21.8M
$42.5M 35.95%
255,263
– –
FATE icon
2
Fate Therapeutics
FATE
$286M
$25.9M 21.9%
1,473,186
-350,000
-19% -$5.52M
KALA icon
3
KALA BIO
KALA
$14.4M
$15.4M 13%
744
– –
STIM icon
4
Neuronetics
STIM
$138M
$11.3M 9.58%
742,289
-82,476
-10% -$1.36M
RNAC icon
5
Cartesian Therapeutics
RNAC
$229M
$6.57M 5.56%
92,449
+38,889
+73% +$2.46M
XFOR icon
6
X4 Pharmaceuticals
XFOR
$374M
$5.42M 4.59%
10,383
– –
TTOO
7
DELISTED
T2 Biosystems, Inc
TTOO
$4.84M 4.1%
368
– –
TRVN
8
DELISTED
Trevena, Inc.
TRVN
$3.2M 2.71%
3,286
– –
GNCA
9
DELISTED
Genocea Biosciences, Inc.
GNCA
$1.16M 0.98%
246,076
– –
ATYR
10
aTyr Pharma
ATYR
$48.1M
$1.01M 0.85%
130,571
– –
DARE icon
11
Dare Bioscience
DARE
$18.4M
$457K 0.39%
27,187
– –
PULM icon
12
Pulmatrix
PULM
$6.35M
$456K 0.39%
17,972
– –

Similar funds

IFC
Intact Financial Corporation Toronto, Ontario, Canada $14M AUM
AG
Ashmore Group London, United Kingdom $16.3M AUM 57.83% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
IR
Invictus RG Hamilton, Bermuda $8.9M AUM 56.32% 1-Year Est. Return
CCM
Copernicus Capital Management San Francisco, California $8.26M AUM 37.91% 1-Year Est. Return
EIP
Edgbaston Investment Partners $20.3M AUM 35.98% 1-Year Est. Return
AAM
Areion Asset Management Hong Kong $7.82M AUM 16% 1-Year Est. Return
OEP
Ocean Endowment Partners Chicago, Illinois $20.6M AUM 27.63% 1-Year Est. Return

Polaris Venture Management Co V's Q1 2019 Portfolio in Review

As of Q1 2019, Polaris Venture Management Co V held 12 positions worth $118M, up 26% from $93.7M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

Polaris Venture Management Co V withdrew a net $4.42M in Q1 2019, reducing 2 holdings. Its largest reduction was Fate Therapeutics, cutting an estimated $5.52M.

By sector, the portfolio is most concentrated in Healthcare at 60% of assets, down from 65% a quarter earlier, followed by Communication Services.

Against the trend, Polaris Venture Management Co V added an estimated $2.46M to Cartesian Therapeutics.

  • Polaris Venture Management Co V added most to Cartesian Therapeutics in Q1 2019, an estimated $2.46M increase.
  • Polaris Venture Management Co V's biggest Q1 2019 reduction was Fate Therapeutics, cutting an estimated $5.52M.
  • Polaris Venture Management Co V's ten largest holdings make up 99% of its $118M portfolio in Q1 2019.
  • Polaris Venture Management Co V opened 0 new positions and closed 0 in Q1 2019.
  • Polaris Venture Management Co V's portfolio value rose 26% quarter-over-quarter to $118M.

Based on Polaris Venture Management Co V's 13F filing for Q1 2019, filed 15 May 2019.